Cytokinetics (CYTK) Insider Trading & Ownership $52.22 +0.20 (+0.38%) (As of 11/27/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cytokinetics (NASDAQ:CYTK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$27.86 M Get CYTK Insider Trade Alerts Want to know when executives and insiders are buying or selling Cytokinetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CYTK Insider Buying and Selling by Quarter Ad PacasoThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.Don’t miss your chance to maximize your stake in this co-ownership revolution. Cytokinetics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/26/2024Fady Ibraham MalikEVPSell7,300$50.16$366,168.00 11/18/2024Robert I BlumCEOSell5,000$50.55$252,750.00 11/12/2024Fady Ibraham MalikEVPSell6,342$58.48$370,880.16 11/1/2024Robert I BlumCEOSell5,000$51.63$258,150.00 10/30/2024Fady Ibraham MalikEVPSell7,300$51.91$378,943.00 10/28/2024Wendall WierengaDirectorSell4,452$52.25$232,617.00 DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late!10/15/2024Fady Ibraham MalikEVPSell7,300$54.19$395,587.00 10/9/2024Robert I BlumCEOSell5,000$55.61$278,050.00 10/1/2024Fady Ibraham MalikEVPSell7,300$52.10$380,330.00 9/30/2024Robert I BlumCEOSell5,000$52.14$260,700.00 9/3/2024Fady Ibraham MalikEVPSell7,384$57.01$420,961.84 9/3/2024Robert I BlumCEOSell5,000$57.03$285,150.00 8/12/2024B Lynne ParshallDirectorSell5,000$55.20$276,000.00 8/12/2024Robert I BlumCEOSell11,500$55.17$634,455.00 8/6/2024Fady Ibraham MalikEVPSell7,300$53.71$392,083.00 7/30/2024Robert I BlumCEOSell11,500$59.49$684,135.00 7/29/2024B Lynne ParshallDirectorSell5,000$59.84$299,200.00 7/23/2024Fady Ibraham MalikEVPSell7,300$57.02$416,246.00 7/15/2024B Lynne ParshallDirectorSell5,000$55.82$279,100.00 7/10/2024Robert I BlumCEOSell11,500$54.29$624,335.00 7/9/2024Fady Ibraham MalikEVPSell7,300$55.90$408,070.00 7/5/2024Robert Arthur HarringtonDirectorSell253$54.61$13,816.33 7/1/2024B Lynne ParshallDirectorSell5,000$54.22$271,100.00 7/1/2024Robert I BlumCEOSell11,500$54.05$621,575.00 6/25/2024Fady Ibraham MalikEVPSell7,300$53.72$392,156.00 6/17/2024B Lynne ParshallDirectorSell5,000$52.55$262,750.00 6/17/2024Robert I BlumCEOSell22,500$52.60$1,183,500.00 6/11/2024Fady Ibraham MalikEVPSell7,788$53.04$413,075.52 6/10/2024Muna BhanjiDirectorSell2,000$52.07$104,140.00 6/4/2024Robert I BlumCEOSell22,500$48.85$1,099,125.00 6/3/2024Robert Arthur HarringtonDirectorSell1,580$48.64$76,851.20 6/3/2024Robert WongCAOSell13,011$48.88$635,977.68 5/7/2024Fady Ibraham MalikEVPSell15,547$65.11$1,012,265.17 4/25/2024John T HendersonDirectorSell10,562$64.54$681,671.48 4/9/2024Fady Ibraham MalikEVPSell32,605$74.31$2,422,877.55 3/5/2024Fady Ibraham MalikEVPSell32,604$67.56$2,202,726.24 2/14/2024John T HendersonDirectorSell5,000$76.48$382,400.00 2/6/2024Fady Ibraham MalikEVPSell32,605$79.30$2,585,576.50 1/31/2024Robert I BlumCEOSell12,500$79.57$994,625.00 1/19/2024Robert I BlumCEOSell12,500$81.42$1,017,750.00 DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late!1/12/2024John T HendersonDirectorSell5,000$85.14$425,700.00 1/4/2024Fady Ibraham MalikEVPSell15,678$86.98$1,363,672.44 1/2/2024Robert I BlumCEOSell12,500$85.08$1,063,500.00 12/27/2023Wendall WierengaDirectorSell10,000$73.60$736,000.00 (Data available from 1/1/2013 forward) CYTK Insider Trading Activity - Frequently Asked Questions Who is on Cytokinetics's Insider Roster? The list of insiders at Cytokinetics includes B Lynne Parshall, Ching Jaw, Edward M Md Kaye, Fady Ibraham Malik, John T Henderson, Mark A Schlossberg, Muna Bhanji, Robert Arthur Harrington, Robert I Blum, Robert Wong, Santo J Costa, and Wendall Wierenga. Learn more on insiders at CYTK. What percentage of Cytokinetics stock is owned by insiders? 3.40% of Cytokinetics stock is owned by insiders. Learn more on CYTK's insider holdings. Which Cytokinetics insiders have been selling company stock? The following insiders have sold CYTK shares in the last 24 months: B Lynne Parshall ($1,388,150.00), Fady Ibraham Malik ($15,351,219.92), John T Henderson ($1,647,121.30), Muna Bhanji ($172,380.00), Robert Arthur Harrington ($90,667.53), Robert I Blum ($18,391,125.00), Robert Wong ($872,156.82), and Wendall Wierenga ($1,161,377.40). How much insider selling is happening at Cytokinetics? Insiders have sold a total of 749,022 Cytokinetics shares in the last 24 months for a total of $39,074,197.97 sold. Cytokinetics Key ExecutivesMr. Robert I. Blum (Age 60)President and Chief Executive Officer Compensation: $1.33M11 recent tradesMr. Robert C. Wong (Age 56)VP & Chief Accounting Officer Compensation: $495.72k1 recent tradesDr. Fady Ibraham Malik FACC (Age 60)M.D., Ph.D., Executive Vice President of Research & Development Compensation: $839.66kMr. Andrew M. Callos (Age 55)Executive VP & Chief Commercial Officer Compensation: $752.84kDr. James A. Spudich Ph.D. (Age 82)Co-Founder & Member of Scientific Advisory Board Compensation: $21.94kMr. Jeff LotzVice President of Sales & OperationsMr. Matt YangVice President of Corporate Finance and Financial Planning & AnalysisMr. Steven M. Cook (Age 65)Senior Vice President of Global Supply Chain Operations & Technical Operations Ms. Kari K. Loeser J.D.VP & Chief Compliance OfficerMr. John O. Faurescu Esq.VP, Associate General Counsel & Corporate Secretary More Insider Trading Tools from MarketBeat Related Companies TEVA Insider Transactions BGNE Insider Transactions MRNA Insider Transactions VTRS Insider Transactions SMMT Insider Transactions GMAB Insider Transactions PCVX Insider Transactions CTLT Insider Transactions SRPT Insider Transactions RVMD Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:CYTK) was last updated on 11/28/2024 by MarketBeat.com Staff From Our Partners25X predicted for “Amazon Coin” – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredTop investors are backing this “unlisted” stockWhen the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | SponsoredThe Great AI-Energy CollisionThe biggest players in AI and tech are desperate to bring this limitless power source online. And fast. It...Porter & Company | SponsoredTrump’s “Magic Pattern” targets stock market boomAccording to millionaire-trader Jeff Clark, President Trump's bold agenda is poised to unleash a historic trad...InvestorPlace | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
